Skip to main content
. 2022 Oct 4;13:1010835. doi: 10.3389/fimmu.2022.1010835

Figure 2.

Figure 2

Geometric mean concentration of anti-RBD IgG at baseline, 4 months after first dose, 2 and 12 weeks after second dose for all study arms. Data from IM-IM vaccine regimens serve as the reference group for comparison (9). Data presented as geometric mean concentrations (GMC) and 95% confidence intervals. P<0.05 is considered statistically significant. BAU, binding antibody units. n= number of participants.